伦敦 - 专注于病毒性疾病诊断的生物技术公司Virax Biolabs Group Limited (NASDAQ: VRAX)已经扩大了与Cosmos Health Inc. (NASDAQ: COSM)的独家分销合作伙伴关系,以在海湾合作委员会(GCC)地区销售其Mpox病毒实时PCR检测试剂盒。这项协议是在Virax现有的希腊、塞浦路斯独家分销权以及欧洲非独家分销权的基础上进一步扩展。 这些 ...
The resurgence of mpox during 2024 has been declared a continental emergency by the Africa Centres for Disease Control and Prevention (Africa CDC) and a Public Health Emergency of International ...